These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27810316)

  • 21. Catching-up with pentavalent vaccine: Exploring reasons behind lower rotavirus vaccine coverage in El Salvador.
    Suarez-Castaneda E; Burnett E; Elas M; Baltrons R; Pezzoli L; Flannery B; Kleinbaum D; de Oliveira LH; Danovaro-Holliday MC
    Vaccine; 2015 Nov; 33(48):6865-70. PubMed ID: 26263200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Residual Vaccine-preventable Burden of Rotavirus Disease.
    Sederdahl BK; Yi J; Jerris R; Gillespie SE; Westblade L; Kraft CS; Shane AL; Lopman B; Anderson EJ
    Pediatr Infect Dis J; 2017 Aug; 36(8):780-781. PubMed ID: 28221240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implementation of rotavirus immunization in Philadelphia, Pennsylvania: high levels of vaccine ineligibility and off-label use.
    Daskalaki I; Spain CV; Long SS; Watson B
    Pediatrics; 2008 Jul; 122(1):e33-8. PubMed ID: 18595974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of an incomplete RotaTeq (RV5) vaccination regimen in preventing rotavirus gastroenteritis in the United States.
    Wang FT; Mast TC; Glass RJ; Loughlin J; Seeger JD
    Pediatr Infect Dis J; 2013 Mar; 32(3):278-83. PubMed ID: 23014356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The first oral rotavirus vaccine, 1998-1999: estimates of uptake from the National Immunization Survey.
    Smith PJ; Schwartz B; Mokdad A; Bloch AB; McCauley M; Murphy TV
    Public Health Rep; 2003; 118(2):134-43. PubMed ID: 12690067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction in gastroenteritis with the use of pentavalent rotavirus vaccine in a primary practice.
    Bégué RE; Perrin K
    Pediatrics; 2010 Jul; 126(1):e40-5. PubMed ID: 20587671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modelling the epidemiological impact of rotavirus vaccination in Germany--a Bayesian approach.
    Weidemann F; Dehnert M; Koch J; Wichmann O; Höhle M
    Vaccine; 2014 Sep; 32(40):5250-7. PubMed ID: 25045820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Why Aren't We Achieving High Vaccination Rates for Rotavirus Vaccine in the United States?
    Kempe A; O'Leary ST; Cortese MM; Crane LA; Cataldi JR; Brtnikova M; Beaty BL; Hurley LP; Gorman C; Tate JE; St Pierre JL; Lindley MC
    Acad Pediatr; 2022; 22(4):542-550. PubMed ID: 34252608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination with 3-dose paediatric rotavirus vaccine (RotaTeq®): impact on the timeliness of uptake of the primary course of DTPa vaccine.
    Wendy B
    Vaccine; 2012 Jul; 30(35):5293-7. PubMed ID: 22575163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial.
    Zaman K; Dang DA; Victor JC; Shin S; Yunus M; Dallas MJ; Podder G; Vu DT; Le TP; Luby SP; Le HT; Coia ML; Lewis K; Rivers SB; Sack DA; Schödel F; Steele AD; Neuzil KM; Ciarlet M
    Lancet; 2010 Aug; 376(9741):615-23. PubMed ID: 20692031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rotavirus vaccination of very low birth weight infants at discharge from the NICU.
    Stumpf KA; Thompson T; Sánchez PJ
    Pediatrics; 2013 Sep; 132(3):e662-5. PubMed ID: 23940248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants.
    Ruiz-Palacios GM; Guerrero ML; Bautista-Márquez A; Ortega-Gallegos H; Tuz-Dzib F; Reyes-González L; Rosales-Pedraza G; Martínez-López J; Castañón-Acosta E; Cervantes Y; Costa-Clemens S; DeVos B
    Pediatrics; 2007 Aug; 120(2):e253-61. PubMed ID: 17606534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevaccination Rotavirus Serum IgG and IgA Are Associated With Lower Immunogenicity of Live, Oral Human Rotavirus Vaccine in South African Infants.
    Moon SS; Groome MJ; Velasquez DE; Parashar UD; Jones S; Koen A; van Niekerk N; Jiang B; Madhi SA
    Clin Infect Dis; 2016 Jan; 62(2):157-65. PubMed ID: 26400993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of the introduction of rotavirus vaccine on the timeliness of other scheduled vaccines: the Australian experience.
    Hull BP; Menzies R; Macartney K; McIntyre PB
    Vaccine; 2013 Apr; 31(15):1964-9. PubMed ID: 23422140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial.
    Armah GE; Sow SO; Breiman RF; Dallas MJ; Tapia MD; Feikin DR; Binka FN; Steele AD; Laserson KF; Ansah NA; Levine MM; Lewis K; Coia ML; Attah-Poku M; Ojwando J; Rivers SB; Victor JC; Nyambane G; Hodgson A; Schödel F; Ciarlet M; Neuzil KM
    Lancet; 2010 Aug; 376(9741):606-14. PubMed ID: 20692030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States.
    Wang FT; Mast TC; Glass RJ; Loughlin J; Seeger JD
    Pediatrics; 2010 Feb; 125(2):e208-13. PubMed ID: 20100757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rotavirus vaccine series completion and adherence to vaccination schedules among infants in managed care in the United States.
    Krishnarajah G; Davis EJ; Fan Y; Standaert BA; Buikema AR
    Vaccine; 2012 May; 30(24):3717-22. PubMed ID: 22214886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis of vaccination situation of orial live attenuated rotavirus vaccine (LLR strain) among children in 6 provinces of China].
    Liu Y; Yue CY; Li Y; Wang YM; Gao SR; Wang ZG; Xie X; Zhao HP; Wang D; Liang XF; An ZJ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Mar; 52(3):282-286. PubMed ID: 29973008
    [No Abstract]   [Full Text] [Related]  

  • 39. European Society for Paediatric Infectious Diseases consensus recommendations for rotavirus vaccination in Europe: update 2014.
    Vesikari T; Van Damme P; Giaquinto C; Dagan R; Guarino A; Szajewska H; Usonis V
    Pediatr Infect Dis J; 2015 Jun; 34(6):635-43. PubMed ID: 25860532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of rotavirus disease: updated guidelines for use of rotavirus vaccine.
    ;
    Pediatrics; 2009 May; 123(5):1412-20. PubMed ID: 19332437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.